CCA - Treatment and quality of life (VUmc)

Floor Abbink
- Paediatrics (VUmc) - Medical Specialist
- CCA - Cancer biology and immunology (VUmc) - Medical Specialist
- CCA - Treatment and quality of life (VUmc) - Medical Specialist
- AII - Cancer immunology (VUmc) - Medical Specialist
Person: Academic
20112021
Hoda Al-Itejawi
- CCA - Treatment and quality of life (VUmc) - Research Associate
- CCA - Cancer biology and immunology (VUmc) - Research Associate
Person: Academic
20152020
Han Anema
- APH - Societal Participation & Health (VUmc) - Full Professor
- Public Health (VUmc) - Full Professor
- CCA - Treatment and quality of life (VUmc) - Full Professor
Person: Academic
20022021

11C-Sorafenib and 15O-H2O PET for Early Evaluation of Sorafenib Therapy
Mammatas, L. H., Yaqub, M., Hendrikse, N. H., Hoekstra, O. S., Honeywell, R. J., Schuit, R. C., Meijerink, M., Schwarte, L. A., Peters, G. J., Verheul, H. M. W., Lammertsma, A. A. & Menke-van der Houven van Oordt, C. W., 1 Jul 2021, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 62, 7, p. 934-940 7 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
Eertink, J. J., van de Brug, T., Wiegers, S. E., Zwezerijnen, G. J. C., Pfaehler, E. A. G., Lugtenburg, P. J., van der Holt, B., de Vet, H. C. W., Hoekstra, O. S., Boellaard, R. & Zijlstra, J. M., 18 Aug 2021, (E-pub ahead of print) In: European Journal of Nuclear Medicine and Molecular Imaging.
Research output: Contribution to journal › Article › Academic › peer-review
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
HOVON imaging workgroup, 2 Sep 2021, (E-pub ahead of print) In: European Journal of Nuclear Medicine and Molecular Imaging.
Research output: Contribution to journal › Article › Academic › peer-review